China’s CanSino in mRNA vaccine deal with AstraZeneca R&D, Therapeutics AstraZeneca is China’s largest drugmaker and is doubling down on the world’s No.2 pharmaceutical market amid slumping sales of its COVID vaccine. Read more August 8, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/11/AstraZeneca-and-Oxfords-COVID-19-Vaccine-Shows-Promise-in-Elderly-Adults-BioSpace-11-19-20.jpeg 350 625 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-08-08 07:35:002023-08-08 10:16:06China's CanSino in mRNA vaccine deal with AstraZeneca
